Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$145.48 - $167.38 $5.09 Million - $5.86 Million
-35,000 Reduced 71.28%
14,100 $2.29 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $2.71 Million - $2.97 Million
-18,800 Reduced 27.69%
49,100 $7.18 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $14.4 Million - $15.1 Million
-92,700 Reduced 57.72%
67,900 $10.7 Million
Q4 2023

Feb 01, 2024

BUY
$145.6 - $158.88 $13.1 Million - $14.3 Million
90,300 Added 128.45%
160,600 $25.2 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $8.78 Million - $9.84 Million
-56,400 Reduced 44.51%
70,300 $10.9 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $2.61 Million - $2.81 Million
-16,900 Reduced 11.77%
126,700 $21 Million
Q1 2023

May 08, 2023

BUY
$151.05 - $180.26 $10.4 Million - $12.4 Million
68,700 Added 91.72%
143,600 $22.3 Million
Q4 2022

Feb 01, 2023

SELL
$160.2 - $179.79 $2.88 Million - $3.24 Million
-18,000 Reduced 19.38%
74,900 $13.2 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $9.65 Million - $10.7 Million
59,800 Added 180.66%
92,900 $15.2 Million
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $5.28 Million - $5.84 Million
31,400 Added 1847.06%
33,100 $5.88 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $2.4 Million - $2.64 Million
-18,300 Reduced 91.5%
1,700 $236,000
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $377,160 - $419,370
-3,000 Reduced 13.04%
20,000 $2.8 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $368,520 - $443,520
3,000 Added 15.0%
23,000 $2.97 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $607,900 - $714,400
5,000 Added 33.33%
20,000 $2.76 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $1.88 Million - $2.22 Million
15,000 New
15,000 $1.92 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.